Skye Bioscience, Inc. - Common Stock

Skye Bioscience, Inc. - Common Stock

Share · US83086J2006 · SKYE (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Skye Bioscience, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
0
0
0
No Price
29.04.2026 15:43
Current Prices from Skye Bioscience, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SKYE
USD
29.04.2026 15:43
0,88 USD
-0,05 USD
-5,38 %
XDQU: Quotrix
Quotrix
SBIRSN06.DUSD
EUR
29.04.2026 05:27
0,80 EUR
0,21 EUR
+35,59 %
IEXG: IEX
IEX
SKYE
USD
28.04.2026 18:49
0,92 USD
-0,14 USD
-12,96 %
XDUS: Düsseldorf
Düsseldorf
SBIRSN06.DUSB
EUR
28.04.2026 17:30
0,71 EUR
0,11 EUR
+19,49 %
Share Float & Liquidity
Free Float 60,36 %
Shares Float 21,2 M
Shares Outstanding 35,13 M
Company Profile for Skye Bioscience, Inc. - Common Stock Share
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.

Company Data

Name Skye Bioscience, Inc. - Common Stock
Company Skye Bioscience, Inc.
Symbol SKYE
Website https://skyebioscience.com
Primary Exchange XNAS NASDAQ
ISIN US83086J2006
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Punit S. Dhillon
Market Capitalization 33 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 11250 El Camino Real, 92130 San Diego
IPO Date 2014-11-26

Stock Splits

Date Split
08.09.2023 1:250

ID Changes

Date From To
05.04.2019 NMUS SKYE

Ticker Symbols

Name Symbol
Düsseldorf SBIRSN06.DUSB
Frankfurt 09R.F
NASDAQ SKYE
Quotrix SBIRSN06.DUSD
More Shares
Investors who hold Skye Bioscience, Inc. - Common Stock also have the following shares in their portfolio:
EIKA BOLIGKRED. 15/21 MTN
EIKA BOLIGKRED. 15/21 MTN Bond
SUEZ 15-UND. FLR
SUEZ 15-UND. FLR Bond